Compare
Cryo Cell International Inc vs Marpai, Inc. vs Charming Medical Ltd vs Sotera Health Co
| Latest fiscal year | Cryo Cell International Inc CCEL | Marpai, Inc. MRAI | Charming Medical Ltd MCTA | Sotera Health Co SHC |
|---|---|---|---|---|
| Year ended | 2025-11-30 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $31.57M | $18.10M | $4.81M | $1.16B |
| Revenue growth (YoY) | -1.3% | -35.8% | -22.7% | +5.7% |
| Gross margin | 76.6% (computed) | n/a | n/a | 55.5% |
| Operating margin | 1.5% | -74.9% | -0.6% | n/a |
| Net margin | -7.7% | -91.5% | -0.5% | 6.7% |
| Net income | -$2.43M | -$16.56M | -$22.6K | $77.95M |
| EPS (Diluted) | -$0.30 | -$0.95 | $0.00 | $0.27 |
| Operating cash flow | $5.48M | -$7.45M | -$1.22M | $287.19M |
| Free cash flow | $5.25M | n/a | -$1.56M | $149.18M |
| Cash & equivalents | $319.0K | $133.0K | $4.70M | $344.62M |
| Total assets | $61.73M | $10.90M | $9.87M | $3.26B |
| Total liabilities | $80.33M | $43.47M | $4.69M | $2.66B |
| Shareholders' equity | -$18.61M | -$32.56M | $5.18M | $606.03M |
| Return on year-end equity | n/a | n/a | -0.4% | 12.9% |
| Shares outstanding | 8.06M | 24.04M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Cryo Cell International Inc | Marpai, Inc. | Charming Medical Ltd | Sotera Health Co |
|---|---|---|---|---|
| Latest | $31.57M Ended 2025-11-30 | $18.10M Ended 2025-12-31 | $4.81M Ended 2026-03-31 | $1.16B Ended 2025-12-31 |
| 1 year earlier | $31.99M Ended 2024-11-30 | $28.17M Ended 2024-12-31 | $6.22M Ended 2025-03-31 | $1.10B Ended 2024-12-31 |
| 2 years earlier | $31.34M Ended 2023-11-30 | $37.16M Ended 2023-12-31 | $6.02M Ended 2024-03-31 | $1.05B Ended 2023-12-31 |
| 3 years earlier | $30.34M Ended 2022-11-30 | n/a | n/a | $1.00B Ended 2022-12-31 |
| 4 years earlier | $28.88M Ended 2021-11-30 | n/a | n/a | $931.48M Ended 2021-12-31 |